These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Jean L; Brimijoin S; Vaux DJ J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102 [TBL] [Abstract][Full Text] [Related]
24. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid. Huang TH; Yang DS; Fraser PE; Chakrabartty A J Biol Chem; 2000 Nov; 275(46):36436-40. PubMed ID: 10961999 [TBL] [Abstract][Full Text] [Related]
25. Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses. Cerpa W; Dinamarca MC; Inestrosa NC Curr Alzheimer Res; 2008 Jun; 5(3):233-43. PubMed ID: 18537540 [TBL] [Abstract][Full Text] [Related]
26. Amyloid binding ligands as Alzheimer's disease therapies. Lee VM Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800 [TBL] [Abstract][Full Text] [Related]
28. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology. Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496 [TBL] [Abstract][Full Text] [Related]
29. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage. Ferrera D; Mazzaro N; Canale C; Gasparini L Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120 [TBL] [Abstract][Full Text] [Related]
30. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils. Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812 [TBL] [Abstract][Full Text] [Related]
33. Iron Biochemistry is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer's Disease. Telling ND; Everett J; Collingwood JF; Dobson J; van der Laan G; Gallagher JJ; Wang J; Hitchcock AP Cell Chem Biol; 2017 Oct; 24(10):1205-1215.e3. PubMed ID: 28890316 [TBL] [Abstract][Full Text] [Related]
34. Nitrogen-Doped Carbonized Polymer Dots: A Potent Scavenger and Detector Targeting Alzheimer's β-Amyloid Plaques. Gao W; Wang W; Dong X; Sun Y Small; 2020 Oct; 16(43):e2002804. PubMed ID: 33006250 [TBL] [Abstract][Full Text] [Related]
35. Electrochemistry of Alzheimer Disease Amyloid Beta Peptides. Chiorcea-Paquim AM; Enache TA; Oliveira-Brett AM Curr Med Chem; 2018; 25(33):4066-4083. PubMed ID: 29446720 [TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior. Sharma S; Verma S; Kapoor M; Saini A; Nehru B Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920 [TBL] [Abstract][Full Text] [Related]
38. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Ono K; Tsuji M Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023927 [TBL] [Abstract][Full Text] [Related]
39. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478 [TBL] [Abstract][Full Text] [Related]
40. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease. Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]